Trulicity vs Retatrutide: What to Do When One Fails At a glance Drug class (Trulicity) / GLP-1 receptor agonist (dulaglutide), once-weekly subcutaneous injection Drug class (Retatrutide) / GIP plus GLP-1 plus glucagon receptor triple agonist, once-weekly subcutaneous injection (Phase 3, not yet FDA-approved) Best weight loss (Trulicity) / 3.0 kg mean at 52 weeks in AWARD-11 high-dose arm Best weight loss (Retatrutide) / 24.2% mean body weight reduction at 48 weeks in Phase 2 (N=338) Cardiovascular outcome data / Trulicity: REWIND (N=9,901, Lancet 2019) showed 12% MACE reduction
If your UHC plan covers only the CV indication and you are seeking weight-loss coverage not covered under your plan, the savings card applies only to covered uses at in-network pharmacies
While our bodies can store B12 for years, some groups are more susceptible to deficiency, often because of absorption issues rather than diet
Understanding this distinction helps explain why some people tolerate the combination seamlessly while others experience amplified gastrointestinal symptoms
However, results from animal experiments cannot be extrapolated to clinical settings
